GlassScriptPhysician profile
Melissa M Dowd
NPI 1780993121
$8,010.77
in general payments reported to CMS, 2019-2025
70 companies · $1,526 in 2025
The $1,526 reported for 2025 was more than what 92% of Community Health (Nurse Practitioner) providers received nationally (typical 2025 total: $139).
See the full distribution for Community Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,843 · 2022: $2,017 · 2023: $1,626 · 2024: $998 · 2025: $1,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,048 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,047.56 |
| Education | $102.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $704.71 | 2021-2025 | Darzalex, Talvey, Imbruvica |
| Pharmacyclics LLC, An Abbvie Company | $517.23 | 2021-2023 | Imbruvica, Epkinly |
| Seagen INC. | $500.09 | 2021-2023 | Adcetris, Padcev |
| Merck Sharp & Dohme LLC | $444.80 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $373.82 | 2021-2025 | |
| US Oncology Corporate, INC. | $360.00 | 2022 | |
| Daiichi Sankyo INC. | $343.17 | 2021-2025 | Enhertu |
| Genzyme Corporation | $279.30 | 2021-2024 | |
| Lilly USA, LLC | $267.38 | 2021-2025 | Jaypirca, Retevmo, Verzenio |
| Takeda Pharmaceuticals U.S.A., INC. | $256.65 | 2021-2025 | Fruzaqla, Iclusig, Ninlaro |
| Amgen INC. | $244.96 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $203.35 | 2021-2025 | Lynparza, Tagrisso, Calquence |
| Glaxosmithkline, LLC. | $201.94 | 2021-2025 | Jemperli, Zejula, Blenrep |
| Gilead Sciences, INC. | $196.03 | 2022-2025 | Trodelvy |
| Jazz Pharmaceuticals INC. | $181.44 | 2021-2025 |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Dowd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.